Target intelligence / Profile preview

UBE2H divergent transcript (UBE2H-DT)

Target
UBE2H-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

UBE2H divergent transcript (UBE2H-DT) is a long non-coding RNA gene, classified as an lncRNA. It is genomically adjacent to the UBE2H gene and is named for its divergent orientation with respect to UBE2H, a gene encoding the enzyme ubiquitin-conjugating enzyme E2 H. Currently, there are no published data on functional roles, disease associations, or pharmacological targeting of UBE2H-DT. It does not encode a protein and is not a recognized therapeutic target. UBE2H-DT should not be confused with UBE2H (ubiquitin-conjugating enzyme E2 H), which is a well-studied enzyme relevant to the ubiquitin modification pathway and involved in processes such as protein degradation and cellular homeostasis. All available high-confidence sources classify UBE2H-DT as an lncRNA with no established role in disease or as a drug target.

Other names
UBE2H divergent transcriptUBE2H-DT
02

Mechanism of action

None known

03

Biological functions

Unknown; as a lncRNA, potential regulatory roles are possible but not yet specifically described in the literature
04

Disease associations

None established; no direct evidence links UBE2H-DT to any disease as of current knowledge

Beyond the preview

Go deeper on UBE2H divergent transcript (UBE2H-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBE2H divergent transcript (UBE2H-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call